Viewing Study NCT01729104


Ignite Creation Date: 2025-12-24 @ 8:00 PM
Ignite Modification Date: 2025-12-28 @ 12:43 AM
Study NCT ID: NCT01729104
Status: TERMINATED
Last Update Posted: 2019-10-22
First Post: 2012-11-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I/II Carfilzomib Plus Lenalidomide and Rituximab in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module